Distribution and clinical significance of circulating CD8+CD28- regulatory T cells in the peripheral blood of patients with pulmonary tuberculosis

被引:4
|
作者
Yu, Xin [1 ,2 ]
Lin, Yao [2 ]
Chen, Hui [1 ]
Wu, Min-Juan [1 ]
Huang, Li-Na [1 ]
Song, Yi-Yan [1 ]
Gu, Bin-Bin [2 ]
Ye, Zhi-Jian [2 ]
Xu, Ping [1 ]
Zhang, Jian-Ping [2 ]
Xu, Jun-Chi [1 ,2 ]
机构
[1] Fifth Peoples Hosp Suzhou, Dept Clin Lab, 10 Guanqian Rd, Suzhou 215000, Jiangsu, Peoples R China
[2] Soochow Univ, Affiliat Infect Dis Hosp, Dept Resp, 10 Guangqian Rd, Suzhou 215000, Jiangsu, Peoples R China
关键词
CD8(+)CD28(-) Treg; Tuberculosis; Immune response; ACTIVATION; CANCER;
D O I
10.1186/s12890-022-02088-7
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background Regulatory T cells (Treg cells) in the peripheral blood of patients with pulmonary tuberculosis (PTB) may be closely related to the progression of PTB. In this study, the distribution characteristics and clinical importance of CD8(+)CD28(-) Treg cells in patients with tuberculosis were systematically analyzed, and the role and importance of CD8(+)CD28(-) Treg cells in influencing the immune response and progression of tuberculosis were discussed, which will provide immunological indices and reference values for the clinical diagnosis of tuberculosis. Methods Flow cytometry, sputum smears and computed tomography imaging were used to analyze the distribution characteristics of CD8(+)CD28(-) Treg cells in the peripheral blood of patients with PTB and the correlation between CD8(+)CD28(-)Treg cells and clinical and immune indices. Results The percentages of CD4(+)CD25(high) and CD8(+)CD28(-) Treg cells in the peripheral blood of patients with PTB were significantly higher than those in the healthy control (HC) group. Further analysis showed that the percentage of CD4(+)CD25(high)Treg cells in the Stage II group was significantly higher than that in the HC group. The percentages of CD4(+)CD25(high) and CD8(+)CD28(-) Treg cells increased significantly in patients in the Stage II group. The proportion of CD8(+)CD28(-) Treg cells was directly proportional to the degree of positivity in sputum smears, while CD4(+)CD25(high)Treg cells did not exhibit this trend. The correlations between the percentage of CD4(+)CD25(high) and CD8(+)CD28(-) Treg cells and the percentage of lymphocyte subsets were examined. The percentage of CD8(+)CD28(-) Treg cells was negatively correlated with the percentage of CD4(+)T cells and positively correlated with the CD8(+)T cell percentage in the HC and PTB groups. The percentage of CD4 + CD25(high)Treg cells was positively correlated with the percentage of CD4(+)T cells only in the PTB group. Conclusions This study was the first to show that the proportion of CD8(+)CD28(-) Treg cells in the peripheral blood of patients with PTB was significantly increased, and the increase in CD8(+)CD28(-) Treg cells was related to the progression of PTB, which may affect the proportion of immune cell subsets by inhibiting the immune response, resulting in the progression of PTB.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Distribution and clinical significance of circulating CD8+CD28− regulatory T cells in the peripheral blood of patients with pulmonary tuberculosis
    Xin Yu
    Yao Lin
    Hui Chen
    Min-Juan Wu
    Li-Na Huang
    Yi-Yan Song
    Bin-Bin Gu
    Zhi-Jian Ye
    Ping Xu
    Jian-Ping Zhang
    Jun-Chi Xu
    [J]. BMC Pulmonary Medicine, 22
  • [2] Regulatory functions of CD8+CD28- T cells in an autoimmune disease model
    Najafian, N
    Chitnis, T
    Salama, AD
    Zhu, B
    Benou, C
    Yuan, XL
    Clarkson, MR
    Sayegh, MH
    Khoury, SJ
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (07): : 1037 - 1048
  • [3] Lenalidomide overcomes the immunosuppression of regulatory CD8+CD28- T-cells
    Neuber, Brigitte
    Dai, Jingying
    Waraich, Wjahat A.
    Awwad, Mohamed H. S.
    Engelhardt, Melanie
    Schmitt, Michael
    Medenhoff, Sergej
    Witzens-Harig, Mathias
    Ho, Anthony D.
    Goldschmidt, Hartmut
    Hundemer, Michael
    [J]. ONCOTARGET, 2017, 8 (58) : 98200 - 98214
  • [4] Harnessing CD8+CD28- Regulatory T Cells as a Tool to Treat Autoimmune Disease
    Ceeraz, Sabrina
    Thompson, Charlotte R.
    Beatson, Richard
    Choy, Ernest H.
    [J]. CELLS, 2021, 10 (11)
  • [5] CD8+CD28- T cells: not only age-related cells but a subset of regulatory T cells
    Xiaoyong Chen
    Qiuli Liu
    Andy Peng Xiang
    [J]. Cellular & Molecular Immunology, 2018, 15 : 734 - 736
  • [6] Foxp3 expressing CD4+ CD25+ and CD8+CD28- T regulatory cells in the peripheral blood of patients with lung cancer and pleural mesothelioma
    Meloni, Federica
    Morosini, Monica
    Solari, Nadia
    Passadore, Ileana
    Nascimbene, Caterina
    Novo, Monique
    Ferrari, Marco
    Cosentino, Marco
    Marino, Franca
    Pozzi, Ernesto
    Fietta, Anna M.
    [J]. HUMAN IMMUNOLOGY, 2006, 67 (1-2) : 1 - 12
  • [7] Imbalance between CD8+CD28+ and CD8+CD28- T-cell subsets and its clinical significance in patients with systemic lupus erythematosus
    Minning, S.
    Xiaofan, Y.
    Anqi, X.
    Bingjie, G.
    Dinglei, S.
    Mingshun, Z.
    Juan, X.
    Xiaohui, J.
    Huijuan, W.
    [J]. LUPUS, 2019, 28 (10) : 1214 - 1223
  • [8] Increased Percentage of CD8+CD28- Regulatory T Cells With Fingolimod Therapy in Multiple Sclerosis
    Houston, Timothy W.
    Howlett-Prieto, Quentin
    Regenauer, Colin
    Testai, Fernando D.
    Yao, Faith
    Feng, Xuan
    Reder, Anthony T.
    [J]. NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2023, 10 (02):
  • [9] Antigen-specific recognition is critical for the function of regulatory CD8+CD28- T cells
    Renner, P.
    Popp, F. C.
    Eggenhofer, E.
    Slowik, P.
    Piso, P.
    Geissler, E. K.
    Schlitt, H. J.
    Dahlke, M. H.
    [J]. TRANSPLANT IMMUNOLOGY, 2010, 22 (3-4) : 144 - 149
  • [10] Peripheral circulating Ts (CD8+CD28-)/CD8+is elevated in non small cell lung cancer patients
    Liang, Hailong
    Zhao, Jing
    Xing, Guosheng
    Cai, Huiyun
    Liu, Jing
    Wei, Wenqing
    Chu, Xiangyang
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (11): : 21521 - 21527